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Summary.-As assessed by decrease in tumour volume and inhibition of tumour
cell respiration and glycolysis, hyperthermia (intra-tumour temperature 42°C for
one hour) potentiated the destructive effect of radiotherapy (1000 rad) on the allo-
geneic VX2 carcinoma in the hind limb of rabbits, and chemotherapy (methotrexate)
produced a similar potentiation of irradiation. The resulting regression of the
primary tumour in each case after dual therapy was comparable to that occurring
after 3 applications of local hyperthermia, which has been shown to cure 50o0 of
animals with this carcinoma. Combination therapy did not increase the survival
time of the rabbits, however, all of which had lung and lymph node metastases at
autopsy. The results focus attention on the relationship between a primary tumour
and its metastases. The histological picture and the animal survival data suggest
that the mechanism oftumour cell death and resorption of necrotic material following
treatment may be important in enabling the host to deal with metastatic cells.
After combination therapy, many metabolically and mitotically active cancer cells
remained in the tumour mass, and the incomplete destruction of the primary tumour
may have left the host with a burden of tumour cells too large to be destroyed by the
immune system.
THE possibility of selectively destroy-
ing cancer cells by hyperthermia (tempera-
tures in excess of 40°C) has been recog-
nized for over a hundred years, and there
have been sporadic attempts to treat
cancer in humans by elevated temperature
(Cavaliere et al., 1967; Vermel and
Kuznetsova, 1970). The value of the
technique is illustrated by the striking
success achieved by Cavaliere et al. (1967)
in treating primary cancers of the limbs
by regional perfusion with prewarmed
blood to elevate the tumour temperature
to the region of 42°C. Von Ardenne in
East Germany has proposed the use of
total body heating as a means of destroy-
ing metastatic as well as primary cancer
cells; to this end Von Ardenne immerses
patients in a specially designed water
tank to elevate body temperature as the
basis ofhis multiphase approach to cancer
therapy (Krebs-Mehrschritt-Therapie
Von Ardenne, 1971). At the Ringberg
Klinik, Issels also employs total body
hyperthermia as a clinical adjuvant to
cancer therapy; in this case hyperpyrexia
is induced by injection of anE. coli "auto-
vaccine " (Issels, 1970), a more capricious
and inconsistent method of raising body
temperature than that of Von Ardenne.
The sensitizing effect of elevated
temperature on the response of tumours
to irradiation was described more than
60 years ago, and numerous investigators
have attempted to exploit this effect
clinically, especially in relation to radio-
resistant tumours (see the comprehensive
review by Selawry, Carlson and Moore,
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1 958). In spite of these reports, and the
later confirmatory work of C(rile (1 962),
combina,tion therapy has never become
accepted practice. Tl'he published data
have often beeni iniadequate and lacked
controls; much of the clinical work was
evaluated oni the personal experience of
the investigator rather than against objec-
tive criteria.
Similarly, a beneficial synergistic actionl
of elevated temperature and cytotoxic
drugs (usually alkylating agents) on tranis-
plantable ainimal tumours has been re-
ported by several workers (see Suzuki,
1.967). More recenitly, Giovanella, Lohman
and fHeidelberger (1970) found that in an
in vitro-in vivo L1210 mouse leukaemia
test system, hyperthermia in combination
wvith L-erythro-a, /i-dihydroxybutyra,lde-
hyde (DHBA) was 100-fold more effective
than each treatment applied separately.
Giovanella et l. (1970) suggested that
DHBA, DL-glyceraldehyde and phenyl-
alanine mustard should be considered for
clinical trial at elevated temperature, and
Stehlin (1969) has demonstrated that the
effect of phenylalanine mustard on human
melanomas a,nd sarcomata of the limbs
treated by regional I)erfusion is consider-
ably augmented at perfusioin fluid tem-
peratures above 42°C.
The full potential of hyperthermia in
cancer therapy has not yet been realized,
however, because of lack of precise know-
ledge regarding the optimal conditions of
heating (exact temperature to be used,
duration of application) and the suscepti-
bility ofvarious tumours, and also because
of technical difficulties concerning the
application of the heat (see Dickson and
Muckle, 1972).
Wre have beeni investigatiing these
problems using the VX2 carcinoma in the
rabbit. Heat has a selective destruetive
effect on a wide spectrum of animal
tumours, including a variety of spon-
taneous cancers in dogs (Crile, 1962),
several types of syngeneic tumours in
mice (Crile, 1963; Overgaard and Over-
gaard, 1972), and the classic allogeneic
tumours in rats (e.y. Walker 256 carcino-
sarcoma, Flexner-Jobling carcinoma, Jen-
sen sarcoma) and mice (Sarcoma 180,
melanoma 891) (see Cavaliere et al., 1967;
Vermel and Kuznetsova, 1970). From
immuniological studies, Hellstro mn anid
Hellstr6m (1969) proposed that the VX2
allograft in the rabbit represenited a
system for bridging the gap between
tumours in inbred mice anid in mani.
Hyperthermia has been delineated in
terms of intra-tumour temperature, and
immersion of the tumour-bearing limb of
the rabbit in a waterbath (local hyper-
thermia) on 3 occasions to maintain an
intra-tumour temperature of 420C( for
one hour on eachi occasioni led to wide-
spread cell destruction, with complete
disappearance of the tumour in 50 0 of
a series of treated rabbits (Muckle and
Dickson, 1971). The survivors show no
signs of tumour more than 2 years after
heating, whereas all control rabbits died
within 10 weeks of tumour cell inocula-
tion.
In the current investigationi, the adju-
vant effect of a non-curative (sub-optimal)
application of local hyperthermia in com-
bination with a sub-optimal dose of
radiotlherapy or chemotherapy (metho-
trexate) has been examined, and the
results on the primary tumour and animal
survival are compared with those from
fractionated local heating.
AIATERIALS AND METHODS
T'lhe VX2 tuimour is a highly mnalignant,
transplantable carcinoma which originated
in a Shope virus-induced papilloma of a
domestic rabbit over 30 years ago (Kidd and
Rous, 1940). The tumour is characterized
by rapid and predictable metastasis to lymph
inodes and lungs (Edwards, 1969), and in our
experience the established tumour has never
regressed spontaneously. In the present
w%ork, the tumour was passaged by periodic
transfer of one million cells into the thigh
muscles of outbred male Newr Zealand wAhite
rabbits (Muckle and Dickson, 1971). The
resulting tumour became palpable betwreen
3 and 4 weeks later, and the volume increased
exponentially from 5 to 9 weeks; untreated
rabbits died with metastases at 10 weeks
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(meani survival time 70 ± 6 days), when the
primary tumour volume was 230 + 33 ml
(Dickson and Muckle, 1972). Therapy was
applied at 35 days after cell inoculation when
the tumoui had a diameter of 3-4 cm, a
volume of approximately 40 ml, and wvas
relatively non-necrotic. Tumour volumes
were calculated from caliper measurements
in 3 planes of the leg at weekly intervals,
allowvance being made for the normal tissues
of the thigh (Muckle and Dickson, 1971).
In vivo studies.- For treatment of the
tumours by hyperthermia or radiotherapy,
the rabbit was anaesthetized with intra-
venous Nembutal, 0-6 ml/kg body weight
(Nembutal veterinary, 60 mg pentobarbitone
sodium per ml, Abbott Laboratories). Local
hyperthermia was applied by immersion of
the hind limb) in a water-bath at 460C; when
an intra-tumour temperature of 42°C was
reached, it was maintained for one hour.
Tumour and rectal temperatures were mea-
sured throughout the experimental period,
using a Cambridge potentiometer (type44228)
with copper-constantan thermocouple elec-
trodes; the needle electrodes inserted into the
tumour mass were sensitive to temperature
change only at the needle tip. The instru-
ment records temperature with an accuracy
of +40-1C.
For radiotherapy, 1000 rad TD wvas ap-
plied by superficial radiation fromn 2 opposing
fields, using a field size of 7 cm and 25 cm
FSD. The tube was operated at 140 kV,
8 mA and the filtration was 0-2 mm copper
and 1 0 mm aluminium. For combined
therapy, irradiation was given within 2 hours
following hyperthermia. Chemotherapy con-
sisted of methotrexate given by 6 daily intra-
venous injections of 0 4 mg/kg into the ear
vein, beginning on Day 35 after tumour
inoculation. In combination therapy, heating
or irradiation was performed on Day 38, 4
days after starting the course of metho-
trexate.
In vitro studies.-Cells w%Nere obtained
from treated and control tumours by enzy-
matic digestion Mwith trypsin and DNase
(Muckle and Dickson, 1971); the disaggrega-
tion process does not damage VX2 cell
respiration or glycolysis (Dickson and
Muckle, 1972).
For Warburg manometry, 5-10 x 106
tumour cells were incubated at 37 50C. A
Tris-HCl-sucrose buffer, pH 7 4, was used
for respiration studies, and oxygen uptake
was expressed ass 1l per mg dry weight of
tissue per hour (Qo2). For anaerobic glyco-
lysis measurements, a Tris-HCl-bicarbonate
buffer, pH 7 4, and containing glucose (2 g/l)
was einployed; results were expressed as ,ul
CO2 produced per mg dry weight oftissue per
hour (QCo0). Further details of the mano-
metric techinique have been described pre-
viously (Muckle and Dickson, 1971).
RESULTS
Fig. I records the intra-tumour tem-
perature in the VX2 carcinomata during
local hyperthermia. An intra-tumour
temperature of 42°C was achieved within
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FIG. 1. Int!ra-tumour and rectal temperature
recordings during local hyperthermia to the VX2
carcinoma. The tumour bearing limb was
immerse(l in a waterbath at 46°C for 75 min.
Each point is the mean - standard deviation, and
the figures in brackets indicate the number of'
tumours studlied at each point on the appropriate
curve. The stippledi region denotes the range of
rectal temperature measured under resting con-
dlitions in the series of 56 experimental and control
rabbits.
30 min of limb immersion, and an average
temperature of 42-9 ± 0-3°C was main-
tained between 15 and 75 min. During
this one-hour heating period, the rectal
temperature increased to remain slightly
outside the range considered normal for
the rabbits.
Tumour growth
Figs. 2, 3 and 4 show the response of
the primary tumour to the various treat-
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ments employed. Each method of
therapy, when applied individually, re-
sulted initially in a restraint of tumour
growth compared with untreated tumours;
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FIG. 2, 3, 4. Changes in mean VX2 tumour volume
following various combinations of hyperthermia,
radiotherapy and chemotherapy (methotrexate).
Hyperthermia, applied by waterbath immersion
on Day 35 after tumour cell inoculation, was
followed within 2 hours by 1000 rad irradiation to
the tumour area (Fig. 2); for methotrexate com-
binations, the drug (0-4 mg/kg body weight/day,
i.v.) was given on Days 35-40 after inoculation,
and a single treatment of hyperthermia (Fig. 3),
or radiotherapy (Fig. 4) given on Day 38. The
figures in brackets indicate the number of tum-
[12] ours (animals) studied at each point on the curves.
the difference in volume of the control
[61 and treated tumours was statistically significant (P < 0 001) at the 8th week
after tumour inoculation for all 3 methods
of therapy. Subsequently, the tumours
treated by heating or by methotrexate
[91 increased in volume, whereas the irradi-
[6] ated tumours decreased in volume. Fol-
lowing combination therapy, tumour vol-
ume continued to increase for a further
2 weeks. Thereafter, the tumours given
radiotherapy plus hyperthermia, or radio-
therapy plus methotrexate, decreased in
volume, the tumour volume measure-
ments for both types ofdual therapy being
comparable'at each time point (P > 0.05),
1 2 3 4 5 6 7 8 9 10
Weeks
FIG. 3.
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TABLE I.-Respiration (Qo2) and Anaerobic Glycolysis (Qco2, bracketed) of VX2 Cells
Following in vivo Therapy
Therapy
Control cells from untreated VX2
42°C for 1 hour
Radiotherapy
Methotrexate
42°C + radiotherapy
420C + methotrexate
Radiotherapy + methotrexate
24 hours
7-7-9-2*
(13*9-17*1)
2-5-3-3
(14-2-16-4)
4-04-47
(8 0-8 8)
9-8 10-6
(14-4 15-6)
3 3-4 0
(7-0-8-1)
3-1 3-6
(15-7 16-6)
4-8 5-3
(8-6 9 2)
Each Warburg flask contained 5-10 x 106 cells in Tris-HCl-sucrose buffer (respiration) or Tris-HCl-
bicarbonate buffer (anaerobic glycolysis), at pH 7-4 and 37 5°C. Following treatment involving radio-
therapy, the 10 day and 4 week populations of cells were obtained from the intact peripheral rim of the
tumours. The figures quoted as a range were obtained from 3 separate tumours in each case. All mano-
metric observations were carried out in duplicate flasks.
* The Qo, and Qco, values represent ,ul gas exchanged/mg dry weight of cells/hour over 4 hours.
and the variability about the mean values
being small (Fig. 2, 4). The volumes of
these tumours were significantly less than
the corresponding volumes for tumours
treated by radiotherapy alone (P < 0.05).
For tumours treated by methotrexate in
addition to hyperthermia (Fig. 3), the
changes in volume were not significantly
different to the changes in volume follow-
ing hyperthermia alone (P > 0 05 at all
time points).
Tumour metabolism
Table I records the respiration and
anaerobic glycolysis of the treated tum-
ours at 24 hours, 10 days and 4 weeks
following therapy. Respiration and gly-
colysis of the cell populations were linear
over 4 hours in Warburg flasks, and for
comparison the average Qo2 and Qco2
values over this period have been used.
A one-hour period of heating caused a
rapid decrease in respiration, with subse-
quent recovery of the Qo2 values towards
control level, while anaerobic glycolysis
was unaffected. Radiotherapy, on the
other hand, had a depressive effect on
both respiration and glycolysis, measured
24 hours after therapy, but both these
parameters recovered towards control
values over the following 4 weeks. The
effect of methotrexate was evident at
10 days as an inhibition ofboth 02 uptake
and C02 production; at 4 weeks, however,
the Qo2 and Qco2 valujes had returned to
normal. The effects of combination ther-
apy on respiratory and glycolytic activity
reflected a summation of individual ther-
apies; at 4 weeks there was synergism of
action between radiotherapy and hyper-
thermia or methotrexate, indicated by
persistent marked inhibition of respira-
tion. As reported previously for studies
in vitro (Muckle and Dickson, 1971), and
in vivo (Dickson and Muckle, 1972),
anaerobic glycolysis in the VX2 cells
was more resistant to hyperthermia (alone
or in combination in the present experi-
ments) than respiration. On the other
hand, the susceptibility of tumour glyco-
lysis (anaerobic) to irradiation has been
reported by several workers (see Altman,
Gerber and Okada, 1970).
Histological changes
Following a single application of heat
to the VX2 carcinoma, there was con-
gestion of the small blood vessels so that
the tumour was oedematous and deep red
in colour when sectioned. These changes
have been described previously for heated
mouse tumours by Rohdenburg and
10 days
7-5-9-2
(14-0-17*2)
4-5-5-6
(14-0-16.7)
7-3 8-0
(12-6 13-8)
4-8 4-5
(8-8 10-0)
4- 1-5 5 2
(90-10 0)
3.3 3-8
(9*4 10.2)
4-4 5-5
(8-8 9 8)
4 weeks
7-3-8-9
(13-8-16-9)
6-58-1
(14-1-17*7)
7 0 8-0
(14-0 15-0)
7-6 7-6
(14-0 16-0)
4 0-4 7
(145-16-3)
7-5 8-1
(14-6 16-0)
5-3 5-6
(12-2 13-6)
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DURATION SURVIVAL IN EACH. FORM OF TREATMENT
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FIG. 5. Survival ofrabbits following 6 different therapy schedules. Combination therapy was given
as detailed in Fig. 2-4. The solid black line indicates the mean survival time in untreated rabbits
(70 ± 6 days), and the figures in circles show the number of animals in each group.
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Prime (1921), and in the VX2 there was
no ensuing permanent cell damage after
one heat treatment. The effect of metho-
trexate alone, or in combination with
hyperthermia, was not detectable histo-
logically.
Radiotherapy produced central necro-
sis in the tumour, leaving a peripheral
rim of intact cells in which mitotic figures
were present 4 weeks after therapy, when
the necrotic central area had been replaced
by fibrous tissue. The histological
changes in tumours following radiotherapy
have been described by Rubin and Caser-
ette (I1968). The potentiating effect of
heat or methotrexate produced no striking
alteration in the histological picture fol-
lowing irradiation.
Animal survival
Fig. 5 is a composite picture which
shows the resuilts ofthe various treatments
in terms of animal survival. At the time
of death, all animals in the present series
had metastases in the lungs, inguinal and
para-aortic lymph nodes. It can be seen
that none of the therapies currently
examined produced a worthwhile increase
in survival time, compared with the
control group of rabbits that died within
70 ± 6 days.
DISCUSSION
The iinsensitivity of tumour volume
measurements as the sole criterion in the
assessment of therapy is well recognized,
as a result of work on the relationship
between tumour volume and growth rate
(Mendelsohn, 1963; Mendelsohn and Deth-
lefsen, 1968; Steel, 1968; Steel and
Lamerton, 1969). In spite of the com-
plexity of the situation from the cell
population kinetics point of view (see the
above refs.), marked therapeutically-
induced solid tumour regression can be
taken as a reflection of considerable
tumour cell kill (Skipper, 1968). In the
present experiments, the addition of
either one application of heat or one
course of methotrexate potentiated the
inhibitory effect of radiotherapy oIn the
primary VX2 carcinoma, as assessed by a
significant reduction in tumour volume
(Fig. 2, 4) and inhibition of respiration
and anaerobic glycolysis (Table I). For
both these combination therapies, the
regression line for tumour volume from
the seventh week onward after tumour
transplantation did not differ significantly
in slope from the regression line for
tumour volume following 3 heat applica-
tions, a regimen which led to cure of 50 %
of a series of treated rabbits (Dickson and
Muckle, 1972). However, the biochemical
and histological results indicated that
after combination therapy considerable
numbers of metabolically and mitotically
active VX2 cells remained in the primary
tumour and the animal survival data
corroborated these findings, combination
therapy having little effect on time of
death, compared with the control un-
treated group (Fig. 5).
After a single effective dose of cytotoxic
drug or radiation, cell death, lysis and
resorption follow a variable time course
(Skipper, 1968). In primary VX2 tum-
ours destroyed by heating, the presence
of large numbers of macrophages in the
resolving tumour mass has been consist-
ently noted to be marked and prolonged
(Muckle and Dickson, 1971). The co-
operative effects of macrophages for
antibody production by the degradation
of antigen, and its fixation in the region
of their cell surface, are now recognized
(Roitt, 1971; Weiss, 1972), and it has
been postulated that stimulation of the
immune system in response to tumour
cell breakdown products may be involved
in animal survival following 3 applications
of local hyperthermia, such stimulation
enabling the host to combat metastatic
cells (Dickson and Muckle, 1972). Crile
(1970) has drawn attention to the possi-
bility that a primary tumour may act as
the antigenic source necessary to maintain
immunity against metastases. With tum-
our systems in mice, the incidence of
metastasis was significantly increased
when the foot carrying the tumour was
amputated as when the tumour was
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destroyed by irradiation. Crile suggested
that the cells killed by radiation main-
tained their antigenicity and prolonged
the animal's immunity to the growth of
secondaries during the period that the
primary was disappearing. Vanwijck et
al. (1971) reported that the development
of lung metastases in mice could be inhi-
bited by injecting 1 x 104 live tumour
cells into the left limb at the time of
amputation of the right tumour-bearing
limb. Increasing the number of live
tumour cells increased the incidence of
metastases. Similar observations on the
relationship between primary and meta-
static cancer cells come from Liebelt et al.
(1968), who found a significant increase
in pulmonary metastases in mice after
surgical removal of breast tumours; it
was postulated that the size ofthe primary
tumour was critical in relation to its
influence on the growth and development
of secondaries. In the present experi-
ments, it may be that, following incom-
plete primary tumour destruction by
combination therapy, the residual host
burden of tumour cells was too large to be
overwhelmed by the immune system (see
also Mathe, 1971).
Elevation of temperature results in
active hyperaemia and increased oxygen
tension in the tissues, and it has been
reported that increased oxygen tension
itself has a tumoricidal effect (Kluft and
Boerema, 1963), and potentiates the effect
of irradiation (see Wildermuth, 1964). It
is clear from the literature that heat has a
destructive effect on several types of
malignant cell, and that it can potentiate
the effect of radiotherapy or drugs on
cancer cells. From the present work,
it is also clear that the relationship
between the primary tumour and its
metastases requires consideration in ther-
apy. It may be possible with combina-
tion therapy to avoid the untoward
enhancement of secondary tumours ob-
tained from unbalancing this relationship
(Liebelt et al., 1968; Crile, 1970; Vanwijck
et al., 1971) by concentrating on 100 %
tumour cell kill as advocated by Skipper,
Schabel and Wilcox (1964). Total body
hyperthermia techniques, such as that
introduced recently for controlled eleva-
tion of body temperature in humans
(Henderson and Pettigrew, 1971), offer
the potential of subjecting primary and
secondary cancer cells to deleterious
temperatures, and may prove of value in
this respect.
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